SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: DewDiligence_on_SI who wrote (2789)11/10/2019 2:18:19 AM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 3557
 
I will continue to believe, until prove opposite, that Eylea manufacturing (from the know-how and IP stand points) is not a simple task,...and there are many small tricks that make game interesting. Will see how future will unfold????



To: DewDiligence_on_SI who wrote (2789)11/12/2019 1:36:34 AM
From: CuttingEdge Bio  Respond to of 3557
 
Samsung probably got into biosimilar manufacturing by tracking the communications of US biotech manufacturing employees and directors through their mobile devices. In today's world that wouldn't even register as surprising


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News